Star ratings and testimonial pages are a poor way to evaluate a medical treatment, because they select for whoever felt strongly enough to leave a review, in either direction. A better source is outcome registry and clinical trial data, which tracks results across thousands of patients regardless of whether they were happy enough to post about it. That data paints a more measured picture than either the glowing reviews or the harshest complaints: TMS helps a clear majority of patients with treatment-resistant depression, does not help everyone, and comes with a mild side effect profile compared to medication.
What We Know
|
What patients report as the pros
It works for a population that has already tried medication and failed
TMS is typically offered after at least one antidepressant trial has not produced adequate improvement. Against that backdrop, response rates in the 50 to 60 percent range represent a meaningful jump compared to the roughly 13 to 31 percent remission rates reported for a second or third medication trial in patients with treatment-resistant depression.
A side effect profile that does not resemble medication
Because TMS therapy never enters the bloodstream, it avoids the systemic side effects commonly reported with antidepressants, such as weight gain, sexual dysfunction, or sedation. This shows up repeatedly in patient-reported reviews as a reason people chose TMS over adding another medication.
No downtime
Sessions run 20 to 40 minutes with no anesthesia and no recovery period, so most patients drive themselves and return to work the same day. This is one of the most consistently positive themes in patient feedback compared to treatments like electroconvulsive therapy.
What patients report as the cons
Time commitment
A standard course means daily visits, five days a week, for four to six weeks. This is the single most common complaint in patient reviews, particularly for people balancing work schedules or lacking reliable transportation.
Cost and insurance friction
Even with insurance coverage, prior authorization requirements and documentation of failed medication trials can delay the start of treatment, which shows up frequently in negative reviews as frustration with the process rather than with the treatment itself.
Non-response for a real minority of patients
Roughly 40 to 50 percent of patients do not reach a full response in a standard course. This is the most legitimate basis for a negative review, and it is worth acknowledging directly rather than glossing over, since no treatment for depression works for everyone.
Mild, transient side effects
Scalp discomfort and headache during the first week or two are the most commonly cited downsides in day-to-day patient feedback, though these typically ease as treatment continues.
What “TMS is a hoax” claims usually get wrong
TMS’s effectiveness has been established in randomized, sham-controlled trials, including an NIMH-sponsored study that found significantly higher response and remission rates with active treatment compared to a sham device that mimicked the sensation without delivering therapeutic stimulation. A treatment that only worked through belief in it would not produce a measurable gap between real and sham stimulation in a blinded trial. Claims that TMS is a hoax generally rest on individual non-response stories rather than on the controlled trial evidence, and a non-response is a real and worth-discussing outcome that is different from the treatment having no effect at the population level.
How to read TMS reviews more usefully
- Weight controlled trial and registry data more heavily than star ratings, which reflect a self-selected group of reviewers
- Look for whether a negative review describes a side effect, a non-response, or a scheduling and cost frustration, since these call for different responses
- Ask a prospective provider directly what their own outcome tracking shows, rather than relying only on third-party review sites
Call 646-817-2835 or contact us to book a free consultation.
